Prognosis Research Strategy (PROGRESS) 3: prognostic model research

Ewout W Steyerberg; Karel G M Moons; Danielle A van der Windt; Jill A Hayden; Pablo Perel; Sara Schroter; Richard D Riley; Harry Hemingway; Douglas G Altman; PROGRESS Group

doi:10.1371/journal.pmed.1001381

Prognosis Research Strategy (PROGRESS) 3: prognostic model research

Ewout W Steyerberg, Karel G M Moons, Danielle A van der Windt, Jill A Hayden, Pablo Perel, Sara Schroter, Richard D Riley, Harry Hemingway, Douglas G Altman, PROGRESS Group

Research output: Contribution to journal › Article › peer-review

554 Citations (Scopus)

Abstract

Prognostic models are abundant in the medical literature yet their use in practice seems limited. In this article, the third in the PROGRESS series, the authors review how such models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples.

Original language	English
Pages (from-to)	e1001381
Journal	PLoS Medicine
Volume	10
Issue number	2
DOIs	https://doi.org/10.1371/journal.pmed.1001381
Publication status	Published - Feb 2013

Access to Document

10.1371/journal.pmed.1001381

Cite this

@article{f86d2ca8c21d423cabe9bd898c0c7fac,

title = "Prognosis Research Strategy (PROGRESS) 3: prognostic model research",

abstract = "Prognostic models are abundant in the medical literature yet their use in practice seems limited. In this article, the third in the PROGRESS series, the authors review how such models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples.",

author = "Steyerberg, {Ewout W} and Moons, {Karel G M} and {van der Windt}, {Danielle A} and Hayden, {Jill A} and Pablo Perel and Sara Schroter and Riley, {Richard D} and Harry Hemingway and Altman, {Douglas G} and {PROGRESS Group}",

year = "2013",

month = feb,

doi = "10.1371/journal.pmed.1001381",

language = "English",

volume = "10",

pages = "e1001381",

journal = "PLoS Medicine",

issn = "1549-1676",

publisher = "Public Library of Science (PLOS)",

number = "2",

}

TY - JOUR

T1 - Prognosis Research Strategy (PROGRESS) 3

T2 - prognostic model research

AU - Steyerberg, Ewout W

AU - Moons, Karel G M

AU - van der Windt, Danielle A

AU - Hayden, Jill A

AU - Perel, Pablo

AU - Schroter, Sara

AU - Riley, Richard D

AU - Hemingway, Harry

AU - Altman, Douglas G

AU - PROGRESS Group

PY - 2013/2

Y1 - 2013/2

N2 - Prognostic models are abundant in the medical literature yet their use in practice seems limited. In this article, the third in the PROGRESS series, the authors review how such models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples.

AB - Prognostic models are abundant in the medical literature yet their use in practice seems limited. In this article, the third in the PROGRESS series, the authors review how such models are developed and validated, and then address how prognostic models are assessed for their impact on practice and patient outcomes, illustrating these ideas with examples.

U2 - 10.1371/journal.pmed.1001381

DO - 10.1371/journal.pmed.1001381

M3 - Article

C2 - 23393430

SN - 1549-1676

VL - 10

SP - e1001381

JO - PLoS Medicine

JF - PLoS Medicine

IS - 2

ER -

Prognosis Research Strategy (PROGRESS) 3: prognostic model research

Abstract

Access to Document

Fingerprint

Cite this